
Sign up to save your podcasts
Or


In this episode, Tanuja Randery of AWS sits down with Dave Hallett, Chief Science Officer and Interim CEO of Exscientia, to discuss how the company is leveraging AI and cloud technology to transform the drug discovery process. Hallett explains Exscientia's approach to improving efficiency and patient success rates, and explores the importance of partnerships and building diverse, high-performing teams in the rapidly evolving landscape of scientific innovation.
Resources:
Amazon Bedrock: https://aws.amazon.com/bedrock/
Amazon Q: https://aws.amazon.com/q/
AWS Generative AI Innovation Center: https://aws.amazon.com/generative-ai/innovation-center/
By Amazon Web Services4.6
3030 ratings
In this episode, Tanuja Randery of AWS sits down with Dave Hallett, Chief Science Officer and Interim CEO of Exscientia, to discuss how the company is leveraging AI and cloud technology to transform the drug discovery process. Hallett explains Exscientia's approach to improving efficiency and patient success rates, and explores the importance of partnerships and building diverse, high-performing teams in the rapidly evolving landscape of scientific innovation.
Resources:
Amazon Bedrock: https://aws.amazon.com/bedrock/
Amazon Q: https://aws.amazon.com/q/
AWS Generative AI Innovation Center: https://aws.amazon.com/generative-ai/innovation-center/

538 Listeners

2,676 Listeners

478 Listeners

1,635 Listeners

1,091 Listeners

153 Listeners

302 Listeners

340 Listeners

236 Listeners

212 Listeners

202 Listeners

9,913 Listeners

476 Listeners

209 Listeners

586 Listeners